International Conference on Integrative Oncology
Official title: 21st International Conference of the Society for Integrative Oncology
Funded at Beckman Research Institute/city of Hope · NIH-11000713 · Data updated 2026-11-12
This conference is for healthcare professionals who want to learn about the newest cancer treatments, like CAR T-cell therapy, and share ideas on how to improve care for patients with cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $10,000 |
| NIH project number | 1R13CA294952-01 |
| Project ID | NIH-11000713 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with cancer and their families, as well as healthcare professionals involved in cancer care, would benefit from the findings and discussions presented at this conference.
✕Less likely to help
Patients who are not involved in cancer treatment or do not have a direct interest in integrative oncology may not receive benefits from this conference.
What this research studies
This conference brings together experts in integrative oncology to share knowledge and advancements in cancer treatment, focusing on the latest therapies, including CAR T-cell therapy. Attendees will engage in discussions about the intersection of clinical observation and scientific discovery, aiming to improve patient outcomes. The event features keynote lectures and panels on topics such as natural product drug discovery and the application of artificial intelligence in oncology. It serves as a platform for collaboration among healthcare professionals to enhance cancer care globally.
Why it matters
Potential benefit: If successful, this conference could lead to improved cancer treatment strategies and better quality of life for patients through enhanced collaboration and knowledge sharing.
How similar studies have gone: Previous conferences in integrative oncology have successfully fostered collaboration and led to advancements in cancer treatment, indicating a positive track record for similar initiatives.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Lee, Richard T — Beckman Research Institute/city of Hope
- Study coordinator: Lee, Richard T
Related research
Other NIH-funded projects on the same topics.
-
Targeting the protein-assembly that drives AML growth
Aiming to slow or stop acute myeloid leukemia by blocking how cancer cells make proteins.
-
Metformin for reversing accelerated aging in young adults with metabolic health issues
A practical plan to use metformin to help 18- to 35-year-olds with insulin resistance improve metabolic health and slow aging.
-
PIN1-targeted therapy for pancreatic cancer
A team is developing new PIN1 inhibitors to treat pancreatic cancer that tends to resist current therapies.
-
DNA mismatch repair defects and anti-tumor immunity in cancer
Researchers are studying how defects in a DNA repair system affect the body’s immune response to tumors, to improve cancer treatments that use the immune system.
-
Understanding how skin cancer-associated fibroblasts affect immune detection in early mycosis fungoides
This grant investigates how certain skin cells in early mycosis fungoides might help the cancer hide from the immune system, with findings aiming to improve future patient care.
-
Small-molecule and biologic treatments for glioblastoma using targeted brain delivery
A new approach aims to use FPS-ZM1 to shrink brain swelling and support immunotherapy for glioblastoma, potentially helping patients recover after surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.